Protocol Ledger

NCT03907046 · Phase III · RECRUITING

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Interventional Phase III clinical trial protocol NCT03907046 sponsored by Yale University in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-01-28 Enrollment: 700 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT03907046
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)700 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03907046
Protocol FieldVerified Registry Value
NCT IdentifierNCT03907046
Consolidated Lead SponsorYale University
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment700 participants (ESTIMATED)
Registered Start Date2020-01-28
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT03907046
Hospital Research SiteLocationSite Profile
Mercy San Juan Medical CenterCarmichael, CAOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI